Skip to content
★ Sign in to follow
RB

Rejuvel Bio-Sciences, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by SCIMECA CHARLES J, was filed 09 Nov 2016.

Rejuvel Bio-Sciences, Inc.: what insiders have been doing

Rejuvel Bio-Sciences, Inc. belongs to the Food & Beverage sector. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Rejuvel Bio-Sciences, Inc. The previous disclosure was published on 9 November 2016.

The full history, which starts in 2010, counts 6 purchases against 5 sales.

Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
12
Thresholds
n/a
Buy Volume
€548,628
6 ops. · all time
Sell Volume
€67,570
5 ops. · all time

Since the insiders bought

  • Filed 09 Nov 2016 · 3651 days ago · €3
    -50.0%
    Entry US$0.00 · Close at T+365 US$0.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

US$0.00
Analyst consensus
·
Income statement
EBITDA-US$1.3M
Valuation
Beta-173.04
Profitability & ownership
ROA-329.1%
% institutions0.0%
Last declaration on 9 November 2016
Declarations12 total
  • ▲
    Pres, CEO, Treas, SecretaryExecutives
    20,000 USD0SEC
    6,896,552 shares@ US$0.0029PREFERRED SERIES CSEC:0001469709-16-000940:1
    Canonical exit: 27 Dec 2016 (T+90)
  • ▲
    Pres, CEO, Treas, SecretaryExecutives
    330,000 USD0SEC
    330,000,000 shares@ US$0.001COMMON STOCKSEC:0001469709-16-000940:2
    Canonical exit: 30 Jan 2017 (T+90)
  • ▲
    Pres, CEO, Treas, SecretaryExecutives
    3 USD24SEC
    17,253 shares@ US$0.00020.0% of flowPREFERRED SERIES ASEC:0001469709-16-000940:0
    Canonical exit: 27 Dec 2016 (T+90)
  • ▼
    Pres, CEO, Treas, SecretaryExecutives
    1,481 USD24SEC
    2,468,000 shares@ US$0.00060.9% of flowCOMMON STOCKSEC:0001469709-16-000801:0
  • ▼
    Pres, CEO, Treas, SecretaryExecutives
    68,255 USD0SEC
    4,675,000 shares@ US$0.0146COMMON STOCKSEC:0001469709-16-000714:0
  • ▲
    Pres, CEO, Treas, SecretaryExecutives
    20,000 USD0SEC
    111,607 shares@ US$0.1792PREFERRED SERIES CSEC:0001469709-16-000714:1
    Canonical exit: 26 May 2016 (T+90)
  • ▲
    Pres, CEO, Treas, SecretaryExecutives
    150,000 USD30SEC
    15,000 shares@ US$10.00100.0% of flowSERIES A PREFERREDSEC:0001469709-16-000670:0
    Canonical exit: 26 Apr 2016 (T+90)
  • ▼
    Pres, CEO, Treas, SecretaryExecutives
    3,000 USD0SEC
    3,000,000 shares@ US$0.001COMMON STOCKSEC:0001469709-14-000200:0
  • ▼
    Pres, CEO, Treas, SecretaryExecutives
    1,700 USD0SEC
    1,700,000 shares@ US$0.001COMMON STOCKSEC:0001469709-14-000200:1
  • ▼
    Pres, CEO, Treas, SecretaryExecutives
    100 USD0SEC
    100,000 shares@ US$0.001COMMON STOCKSEC:0001469709-14-000200:2
  • ▲
    CEO President TreasurerExecutives
    101,800 USD0SEC
    101,800,000 shares@ US$0.001Common StockSEC:0001507085-11-000008:0
    Canonical exit: 18 Jan 2012 (T+90)
  • ●
    President, Secretary TreasurerExecutives
    15,000 USD0SEC
    3,000,000 shares@ US$0.005Common StockSEC:0001428209-10-000002:0

12 of 12 declarations

About Rejuvel Bio-Sciences, Inc.

Rejuvel Bio-Sciences, Inc. is a company focused on developing biotechnology solutions for wellness and health. It emphasizes research and innovation in the life sciences sector.